Insmed INSM Total debt

Total debt at other companies

Sarepta Therapeutics, Inc.SRPT

$198.51M-3.4%

Solid Biosciences Inc.SLDB

$20.67M-12.5%

ANI PharmaceuticalsANIP

$305.29M-3.5%

Regeneron PharmaceuticalsREGN

$2.71B+0.1%

SavaraSVRA

$30.07M+1.8%

ArriVent BioPharma, Inc.AVBP

$419K+204%

FAQ

What is Insmed's total debt?

Insmed (INSM) reported total debt of $580.33M in Q1 2026.

How has Insmed's total debt changed year-over-year?

Insmed's total debt decreased by 49.2% year-over-year, from $1.14B to $580.33M.

What is the long-term trend for Insmed's total debt?

Over 5 years (2020 to 2025), Insmed's total debt has grown at a 7.8% compound annual growth rate (CAGR), from $405.92M to $590.02M.

What does total debt mean?

Total debt represents the aggregate sum of all interest-bearing financial obligations, including short-term borrowings, the current portion of long-term debt, and long-term debt instruments. It also encompasses capitalized lease liabilities and other debt-like financing arrangements that require fixed repayment schedules. This metric serves as a comprehensive indicator of a company's total financial leverage and its reliance on external capital providers.